Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IVMT-Rx-3 is a chemical compound that serves as an inhibitor of SDCBP's targeting of the PDZ1 and PDZ2 domains of MDA-9/Syntenin. It effectively blocks the MDA-9/Syntenin-Src interaction, diminishes NF-κB activation, and suppresses MMP-2/MMP-9 expression, thereby inhibiting melanoma metastasis [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | IVMT-Rx-3 is a chemical compound that serves as an inhibitor of SDCBP's targeting of the PDZ1 and PDZ2 domains of MDA-9/Syntenin. It effectively blocks the MDA-9/Syntenin-Src interaction, diminishes NF-κB activation, and suppresses MMP-2/MMP-9 expression, thereby inhibiting melanoma metastasis [1]. |
Molecular Weight | N/A |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IVMT-Rx-3 NF-Κb NF-κB inhibitor inhibit